Interpace Biosciences, Inc. (IDXG) SEC Filings — 2025
12 SEC filings for Interpace Biosciences, Inc. (IDXG) in 2025.
Filings
- Interpace Biosciences, Inc. 8-K Filing — 8-K · Dec 3, 2025
- Interpace Biosciences' Revenue Plummets 14.5% Amid PancraGEN Coverage Loss — 10-Q · Nov 12, 2025
- INTERPACE BIOSCIENCES Files 8-K on Financials — 8-K · Aug 8, 2025
- Interpace Biosciences Narrows Q2 Loss to $1.2M — 10-Q · Aug 7, 2025
- Interpace Biosciences Files Q1 2025 10-Q — 10-Q · May 8, 2025
- INTERPACE BIOSCIENCES, INC. Files 8-K on Exit Costs — 8-K · May 1, 2025
- Interpace Biosciences Files 2024 Annual Report Amendment — 10-K/A · Apr 28, 2025
- INTERPACE BIOSCIENCES, INC. Files 2024 10-K — 10-K · Mar 31, 2025
- Interpace Biosciences Restates Financials — 8-K · Mar 6, 2025
- INTERPACE BIOSCIENCES, INC. Files 8-K on Exit Costs — 8-K · Jan 27, 2025
- INTERPACE BIOSCIENCES Enters Material Agreement, Faces Exit Costs — 8-K · Jan 21, 2025
- INTERPACE BIOSCIENCES, INC. Files 8-K — 8-K · Jan 10, 2025